The Rising Popularity of Cialis
On the whole, the popularity of impotence and erectile dysfunction drugs has remained constant throughout America (and most of the world for that matter) for the last five years. This means that approximately the same number of people are using the drugs these days to improve their sexual performance, when compared to the usage levels five years ago.
But one of the major changes which has taken place is the proportion of sales which have been distributed around specific product in this industry. For example, the first product to be launched to assist with erectile dysfunction issues was Viagra - and at the time of its launch, its market share was 100%.
These days, its market share sets at around 60%, and it is gradually falling month after month. So which other drugs have taken over? Cialis is a major contender in this arena, and definitely a drug worth keeping an eye on in the future.
Cialis Gradually Grabbing Market Share
It would be fair to say that over the last few years, the popularity of Cialis has soared, as advertising and marketing campaigns have shown consumers that Viagra is not the only product available to them.
In fact, there are actually a number of benefits of Cialis over other impotence drugs, such as:
- 48 hours of effective support for sexual activity.
- A better safety profile and fewer cases of adverse effects.
- More research and development in Cialis (the drug has been modified three times).
The second point above is a very interesting one. As consumers become ever more concerned about their health, and as healthcare prices continue to skyrocket, side-effects of common drugs are starting to be looked at carefully to see whether or not long-term health can suffer from the consumption of those substances.
Cialis Doesn't Cause Long Term Health Issues
Thankfully, whilst Viagra has been caught up in a scandal regarding blindness and deafness in some patients, Cialis has escaped this debate, as its safety profile and research has completely ruled out such a thing from happening.
Clearly, this gives confidence to consumers, and has potentially contributed to the 30% stake that Cialis has in the impotence and erectile dysfunction treatment market.
As for the future? Well, it looks as if Cialis' growth path is continuing, and the company itself has increased its forecasts for up to a 35% market share by 2012.